We’re excited to announce that we are now offering access to generic semaglutide to eligible customers across Canada. 🇨🇦 As Dr. Sandy Van, Chief Medical Officer of Hims & Hers Canada, shares in our latest newsroom article, this moment represents more than just a new medication option — it reflects a broader shift toward more accessible, patient-centered care for Canadians navigating obesity and metabolic health. Read more: https://bit.ly/4uW9P3N 𝘎𝘦𝘯𝘦𝘳𝘪𝘤 𝘴𝘦𝘮𝘢𝘨𝘭𝘶𝘵𝘪𝘥𝘦 𝘪𝘴 𝘢𝘶𝘵𝘩𝘰𝘳𝘪𝘻𝘦𝘥 𝘧𝘰𝘳 𝘴𝘢𝘭𝘦 𝘣𝘺 𝘏𝘦𝘢𝘭𝘵𝘩 𝘊𝘢𝘯𝘢𝘥𝘢 𝘧𝘰𝘳 𝘵𝘩𝘦 𝘮𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵 𝘰𝘧 𝘛𝘺𝘱𝘦 2 𝘥𝘪𝘢𝘣𝘦𝘵𝘦𝘴. 𝘐𝘵 𝘮𝘢𝘺 𝘣𝘦 𝘱𝘳𝘦𝘴𝘤𝘳𝘪𝘣𝘦𝘥 𝘰𝘧𝘧-𝘭𝘢𝘣𝘦𝘭 𝘧𝘰𝘳 𝘸𝘦𝘪𝘨𝘩𝘵 𝘮𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵 𝘪𝘯 𝘢 𝘭𝘪𝘤𝘦𝘯𝘴𝘦𝘥 𝘩𝘦𝘢𝘭𝘵𝘩𝘤𝘢𝘳𝘦 𝘱𝘳𝘰𝘷𝘪𝘥𝘦𝘳'𝘴 𝘴𝘰𝘭𝘦 𝘤𝘭𝘪𝘯𝘪𝘤𝘢𝘭 𝘫𝘶𝘥𝘨𝘮𝘦𝘯𝘵. 𝘏𝘪𝘮𝘴 & 𝘏𝘦𝘳𝘴 𝘊𝘢𝘯𝘢𝘥𝘢 𝘐𝘯𝘤. 𝘥𝘰𝘦𝘴 𝘯𝘰𝘵 𝘤𝘶𝘳𝘳𝘦𝘯𝘵𝘭𝘺 𝘰𝘧𝘧𝘦𝘳 𝘢𝘤𝘤𝘦𝘴𝘴 𝘵𝘰 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘴𝘦𝘳𝘷𝘪𝘤𝘦𝘴 𝘧𝘰𝘳 𝘛𝘺𝘱𝘦 2 𝘥𝘪𝘢𝘣𝘦𝘵𝘦𝘴.
Shawn F.
2mo
Amazing for those that need it. Congratulations on making it available in Canada, here's my 2 cents USD perspective - https://www.linkedin.com/pulse/what-twenty-years-inside-retail-taught-me-executive-health-feinblum-4yzlc/
Great milestone for healthcare accessibility in Canada! Expanding patient-centered options for metabolic health is a significant step forward. Congratulations to Dr. Sandy Van and the entire Hims & Hers Canada team on this impactful launch!
The US model proved the demand. Canada expanding access through telehealth rather than waiting for brick-and-mortar infrastructure to catch up is the smarter move. Patient-centered care shouldn't be geography-dependent.